Plant ID: NPO12993
Plant Latin Name: Polypodium vulgare
Taxonomy Genus: Polypodium
Taxonomy Family: Polypodiaceae
NCBI TaxonomyDB:
58048
Plant-of-the-World-Online:
n.a.
Alterative; Anthelmintic; Cholagogue; Demulcent; Diuretic; Expectorant; Pectoral; Purgative; Tonic
Turkey; Israel; Italy; Finland; India; Spain
CNR2; | |
OPRD1; | |
NR1H4; | |
AKR1B1; AKR1B10; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Peptide receptor (family A GPCR) | OPRD1 | Delta opioid receptor | P41143 | CHEMBL236 |
Small molecule receptor (family A GPCR) | CNR2 | Cannabinoid CB2 receptor | P34972 | CHEMBL253 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0044597; daunorubicin metabolic process | 1.500E-06 | 1.050E-02 | AKR1B1, AKR1B10 |
BP | GO:0008152; metabolic process | GO:0044598; doxorubicin metabolic process | 1.500E-06 | 1.050E-02 | AKR1B1, AKR1B10 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 2.027E-05 | 6.305E-02 | AKR1B1, AKR1B10, NR1H4 |
MF | GO:0003824; catalytic activity | GO:0004033; aldo-keto reductase (NADP) activity | 1.738E-05 | 6.305E-02 | AKR1B1, AKR1B10 |
BP | GO:0032501; multicellular organismal process | GO:0019233; sensory perception of pain | 7.348E-05 | 1.455E-01 | CNR2, OPRD1 |
BP | GO:0050896; response to stimulus | GO:0009636; response to toxic substance | 8.673E-05 | 1.574E-01 | AKR1B1, CNR2, OPRD1 |
MF | GO:0060089; molecular transducer activity | GO:0004949; cannabinoid receptor activity | 7.764E-04 | 2.562E-01 | CNR2 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 7.764E-04 | 2.562E-01 | NR1H4 |
CC | GO:0044464; cell part | GO:0005764; lysosome | 1.949E-03 | 4.645E-01 | AKR1B1, AKR1B10 |
CC | GO:0044464; cell part | GO:0042995; cell projection | 3.316E-03 | 5.902E-01 | AKR1B1, CNR2, OPRD1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00040 | Pentose and glucuronate interconversions | 3.139E-05 | 9.418E-05 | AKR1B10, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 2.169E-05 | 9.418E-05 | AKR1B10, AKR1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00561 | Glycerolipid metabolism | 8.507E-05 | 1.914E-04 | AKR1B10, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00051 | Fructose and mannose metabolism | 2.473E-05 | 9.418E-05 | AKR1B10, AKR1B1 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 1.859E-03 | 3.347E-03 | OPRD1, CNR2 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.763E-02 | 2.644E-02 | NR1H4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 3.382E-02 | 3.805E-02 | AKR1B10, AKR1B1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 2.965E-02 | 3.805E-02 | OPRD1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04022 | cGMP-PKG signaling pathway | 4.106E-02 | 4.106E-02 | OPRD1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
K00-K95: Diseases of the digestive system | Inflammatory bowel disease | K50, K51 | CNR2; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | CNR2; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | CNR2; |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Immune disorder | D80-D89 | CNR2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoporosis | M80-M81, Z79.890 | CNR2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | CNR2; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | CNR2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | CNR2; |